Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
Infection
.
2020 Oct;48(5):805-806.
doi: 10.1007/s15010-020-01441-4.
Epub 2020 May 10.
Authors
Chia Siang Kow
1
,
Syed Shahzad Hasan
2
Affiliations
1
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
2
Department of Pharmacy, University of Huddersfield, Huddersfield, UK. s.hasan@hud.ac.uk.
PMID:
32388676
PMCID:
PMC7211145
DOI:
10.1007/s15010-020-01441-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Glucocorticoids
Humans
Immunoglobulins
Myocarditis*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Glucocorticoids
Immunoglobulins